Recent developments in the radiolabeling of antibodies with iodine, indium, and technetium
- 31 January 1990
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 20 (1) , 80-91
- https://doi.org/10.1016/s0001-2998(05)80178-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodinePublished by Elsevier ,2002
- 99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphyNuclear Medicine Communications, 1989
- Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targetingJournal of Medicinal Chemistry, 1989
- Radioimmunotherapy of cancer: clinical studies and limiting factorsCancer Treatment Reviews, 1987
- In the procurement of stable 99mTc labeled protein using bifunctional chelating agentInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986
- The labeling of high affinity sites of antibodies with 99mTcInternational Journal of Nuclear Medicine and Biology, 1985
- The labeling of DTPA-coupled proteins with 99mTcThe International Journal of Applied Radiation and Isotopes, 1984
- Radioactive Labeling of Antibody: A Simple and Efficient MethodScience, 1983
- Localization of I-131-Labeled Goat and Primate Anti-Carcinoembryonic Antigen (CEA) Antibodies in Patients with CancerInvestigative Radiology, 1982
- Covalent attachment of chelating groups to macromoleculesBiochemical and Biophysical Research Communications, 1977